APHB 9:55 am Ampliphi Biosciences provides update on phase 1 trial in chronic rhinosinusitis patients at Briefing.com Tue 9:55am APHB AmpliPhi Biosciences Provides Update on Phase 1 Trial in Chronic Rhinosinusitis Patients at Business Wire Tue 9:54am
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.